An Innovative Canadian Pharmaceutical Company

Revenue Projected at $150,000,000 by 2025

Sponsored
Message: AGORACOM Small Cap 60: Valeo Pharma Obtains Public Reimbursement For Its Asthma Drugs In Alberta

Share
New Message
Please login to post a reply